Navigation Links
Cell Therapeutics Reports Second Quarter 2013 Financial Results
Date:7/31/2013

omparator therapies assigned by the G-BA under Germany's AMNOG law.  The determination reflected the absence of a comparator under AMNOG law specifically for this stage of aggressive NHL because prior to the approval of PIXUVRI in the European Union (E.U.), there was no therapy specifically approved for this stage of disease. The G-BA also decided that the prescribability for PIXUVRI should be limited to hematologists and oncologists. CTI is currently negotiating pricing with the GKV-SV, the Federal Association of Statutory Health Insurance Funds.

Research and Development:  New Data Presentation on Pacritinib's Safety Profile

  • Reported results from pooled integrated safety analysis from four Phase 1 and 2 clinical studies that demonstrated the safety, tolerability and persistence of pacritinib, CTI's novel, oral JAK2/FLT3 inhibitor, in patients with myelofibrosis at the European Hematology Association Congress.
  • Reported on the publication of a comprehensive article summarizing preclinical and clinical data for pacritinib, authored by Srdan Verstovsek, M.D., Ph.D., et al., in the journal Drugs of the Future 2013.
  • Corporate:  Added to Russell Indices and Established Leadership for SAB

  • Added to Russell Investments' Russell 3000® and Russell Global indices.
  • Named distinguished cancer investigator, Daniel Von Hoff, M.D., F.A.C.P., as Chairman and to lead formation of CTI's Scientific Advisory Board (SAB).
  • Second Quarter 2013 Financial ResultsTotal revenues for the second quarter and the six months ended June 30, 2013 were $0.3 million and $1.4 million, respectively.  The revenues were solely attributable to net product sales of PIXUVRI.  CTI sells PIXUVRI directly to health care providers and through a limited number of wholesale distributors in the E.U.  CTI records product sales upon receipt of the product by the health care provider or distributor, n
    '/>"/>

    SOURCE Cell Therapeutics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
    2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
    3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
    4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
    5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
    6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
    7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
    8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
    9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
    10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
    11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/22/2014)... , July 22, 2014 Research and ... "Cell Culture Market by Equipment, by Reagent, by Application ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... Cell culture is one of the most important and ... the largest application segment of the cell culture market ...
    (Date:7/22/2014)... , July 22, 2014 Research ... "Global IVD Market 2014-2018" report to their offering. ... IVDs are widely used to diagnose, monitor, and assess ... environment. IVD tests provide outcomes for earlier and more ... hospital stay, and provide accurate results. This kind of ...
    (Date:7/22/2014)... , July 22, 2014 Elekta (NSE:EKTAb) and ... that The Christie NHS Foundation Trust ( Manchester, ... a consortium whose mission is to develop the clinical ... radiation therapy system. Such a system would, in principle, ... cancer targets. "The Christie was an ...
    Breaking Medicine Technology:Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 2Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4
    ... SAN FRANCISCO, Calif., June 2 Rigel,Pharmaceuticals, Inc. (Nasdaq: ... a,conference call with simultaneous webcast to discuss the preliminary,results ... novel, oral Syk kinase,inhibitor, in patients with B-cell non-Hodgkin,s ... Participating on the call will be Rigel senior,management and ...
    ... the Federation of Clinical Immunology Societies opens,June 5, ... scientists,and clinicians will convene to present new advances ... the 8th annual meeting of,the Federation of Clinical ... Copley Place., Conference participants will present new ...
    Cached Medicine Technology:Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma 2Leading Immunologists Convene in Boston 2
    (Date:7/22/2014)... 2014 Dr. Jeremy K. Ueno, of ... have recently discussed the reasons for an increase in ... periodontics profession are seeing the amount of referrals they ... fact, one surgeon reported that over 50% of his ... implants have a very high success rate of up ...
    (Date:7/22/2014)... A Florida woman has filed a ... the death of her husband was the result of ... Liebhard LLP reports. According to her complaint, which was ... Southern District of Florida on June 23rd, the decedent ... subdural hemorrhage the following June. Despite emergency treatment, his ...
    (Date:7/22/2014)... The American Society of Hematology (ASH) will honor Michael ... and Robert P. Hebbel, MD, of the University of ... and Prize for their significant research advances in the ... Lecture, named for the late Ernest Beutler, MD, a ... 50 years, is a two-part lectureship that recognizes major ...
    (Date:7/22/2014)... comes to heart disease, Dr. Ross Feldman says women are ... disease was a men,s-only disease, however, data has shown that ... heart disease and are less likely to be adequately diagnosed ... week in the British Journal of Clinical Pharmacology ... women and helps to identify which women are more prone ...
    (Date:7/22/2014)... SIMpalm, a leading Mobile App Development ... Payment System. Forte Mobile Payment app allows merchants to ... and iPad. The app was originally launched in ... This update was for iOS 7.0 compatibility and iPhone ... and is available to download on the iPhone app ...
    Breaking Medicine News(10 mins):Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 3Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:Gene variant identified as a heart disease risk factor for women 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3
    ... Human children are more likely than chimpanzees to collaborate when ... the responses of 3-year-old children in Germany with semi-free-ranging chimpanzees ... children and the chimps were given a task they could ... pull two ends of a rope themselves in order to ...
    ... Reporter , THURSDAY, Oct. 13 (HealthDay News) -- The symptoms ... come on weekdays, specifically when your child should be heading ... and it can take different forms in many age groups. ... school avoidance "remains a serious problem," said Alan Hilfer, director ...
    ... press release is available in Spanish . , ... (USDA) and published recently in the journal Crop Science ... broccoli have not declined since 1975, and that the broccoli ... and other minerals that have made the vegetable a healthy ...
    ... this year,s World Osteoporosis Day (October 20), the International ... a three-step strategy for healthy bones and strong muscles. ... and Mobility at the University of Zurich/Waid City Hospital ... matter how old you are, you can optimize your ...
    ... smoke for a period of months, researchers have new insight ... In the October 14th issue of Cell , ... way to reverse the lung damage underlying these conditions. ... the disease and there has been no therapy to stop ...
    ... -- Researchers at St. Michael,s Hospital have found that people ... brain damage as unilingual people before they exhibit symptoms of ... the onset of the disease. "This is unheard of ... symptoms and now we have the evidence to prove this ...
    Cached Medicine News:Health News:Young Children Collaborate Better Than Chimps 2Health News:Why Johnny Won't Go to School 2Health News:Why Johnny Won't Go to School 3Health News:USDA research demonstrates new breeds of broccoli remain packed with health benefits 2Health News:Three steps to unbreakable bones on World Osteoporosis Day 2Health News:Reversing smoke-induced damage and disease in the lung 2Health News:Toronto researchers find first physical evidence bilingualism delays onset of Alzheimer's symptoms 2
    ... Improved Access in Open Procedures with ... ETS Compact-Flex45 Linear Cutter is designed to ... for open surgical procedures, while simultaneously dividing ... available with either a standard blue cartridge, ...
    ... reusable clip applier is designed for use with ... of which contains eight (8) titanium clips., ... instrument is approximately 12.8" (32.5 cm). The clip ... an appropriately sized Auto Suture trocar sleeve or ...
    ... Suture ENDO CLIP 10 mm applier contains 20 ... and 15 titanium clips in the L size. ... through all appropriately sized Auto Suture trocar sleeves, ... of a converter. After introduction of the ENDO ...
    ACUCLIP Endoscopic Right-Angle Multiple Clip Applier, 10 mm Shaft Diameter with 20, 8 mm Titanium Clips...
    Medicine Products: